A RECENT REVIEW ON: CORONAVIRUS DISEASE 2019
DOI:
https://doi.org/10.22159/ajpcr.2022.v15i7.44547Keywords:
Coronavirus disease 2019, Transmission process, Symptom, Clinical features, TreatmentAbstract
Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first identified in December 2019 in Wuhan, the capital of China’s Hubei province and has rapidly spread all over the world. Until August 2020, >25 million cases of SARS-CoV-2 infection had been confirmed worldwide, causing >800,000 deaths. This disease was named by the World Health Organization (WHO) as COVID-19. Similar to SARS and Middle East Respiratory Syndrome, which are also caused by corona virus infections, COVID-19 mainly causes severe respiratory system damage; however, it also causes damage to multiple organs, including the gastrointestinal tract, the cardiovascular system and the nervous system. According to the WHO, common signs of infection include fever, cough, and respiratory difficulties like shortness of breath. Serious cases can lead to pneumonia, kidney failure, and even death. The main aim of the present review article was to summarize the current knowledge of COVID-19, such as the transmission process, diagnostic methods, clinical feature pathological characteristics, and treatment measures.
Downloads
References
Hui DS, Azhar IE, Madani TA, Ntoumi F, Kock R, Dar O, et al. The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health d the latest 2019 novel coronavirus outbreak in Wuhan, China. Int J Infect Dis 2020;91:264e6.
Chauhan S. Comprehensive review of coronavirus disease 2019 (COVID-19). Biomed J 2020;43:334-40. doi: 10.1016/j.bj.2020.05.023, PMID 32788071
Statement on the Second Meeting of the International Health Regulations. Emergency Committee Regarding the Outbreak of Novel Coronavirus, nCoV. Geneva: World Health Organization; 2005. Available from: https://www.who.int/news-room/detail/30-01- 2020-statement-on-the-secondmeeting- of-the-international-health-regulations-(2005)- emergency-committee-regarding-the-outbreak-of-novel coronavirus-(2019-ncov)
Liu YC, Kuo RL, Shih SR. COVID-19: The first documented coronavirus pandemic in history. Biomed J 2020;43:328-33. doi: 10.1016/j.bj.2020.04.007, PMID 32387617
Middle East Respiratory Syndrome Coronavirus (MERS-CoV). Available from: https://www.who.int/health-topics/middle-east-respiratory-syndrome-coronavirus-mers [Last accessed on 2020 Apr 15].
Coronavirus.jhu.edu. Mapping 2019- ncov. [Last accessed on 2020 Jan 23].
Zhou M, Zhang X, Qu J. Coronavirus disease 2019 (COVID-19). A clinical update. Front Med 2020;14:126-35. doi: 10.1007/s11684- 020-0767-8, PMID 32240462
Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A novel coronavirus from patients with pneumonia in China. N Engl J Med 2020;382:727-33.
Su S, Wong G, Shi W, Liu J, Lai AC, Zhou J, et al. Epidemiology, genetic recombination, and pathogenesis of corona viruses. Trends Microbiol 2016;24:490-502. doi: 10.1016/j.tim.2016.03.003, PMID 27012512
Forni D, Cagliani R, Clerici M, Sironi M. Molecular evolution of human coronavirus genomes. Trends Microbiol 2017;25:35-48. doi: 10.1016/j.tim.2016.09.001, PMID 27743750
Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: Implications for virus origins and receptor binding. Lancet 2020;395:565-74. doi: 10.1016/ S0140-6736(20)30251-8, PMID 32007145
Wu YC, Chen CS, Chan YJ. The outbreak of COVID-19: An overview. J Chin Med Assoc 2020;83:217-20. doi: 10.1097/ JCMA.0000000000000270, PMID 32134861
Chen J. Pathogenicity and transmissibility of 2019-nCoV-A quick overview and comparison with other emerging viruses. Microbes Infect 2020;22:69-71. doi: 10.1016/j.micinf.2020.01.004, PMID 32032682
Sookaromdee P, Wiwanitkit V. Imported cases of 2019-novel coronavirus (2019-nCoV) infections in Thailand: Mathematical modelling of the outbreak. Asian Pac J Trop Med 2020;13:277516.
Harapan H, Itoh N, Yufika A, Winardi W, Keam S, Te H, et al. Coronavirus disease 2019 (covid-19): A literature review. J Infect Public Health 2020;13:667-73. doi: 10.1016/j.jiph.2020.03.019, PMID 32340833
Coronaviridae Study Group of the International Committee on Taxonomy of Viruses. The species severe acute respiratory syndrome-related coronavirus: Classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol 2020;5:536-44. doi: 10.1038/s41564-020- 0695-z, PMID 32123347
Li X, Zai J, Zhao Q, Nie Q, Li Y, Foley BT, et al. Evolutionary history, potential intermediate animal host, and cross-species analyses of SARS-CoV-2. J Med Virol 2020;92:602-11. doi: 10.1002/jmv.25731, PMID 32104911
da Silva SJ, Silva CT, Guarines KM, Mendes RP, Pardee K, Kohl A, et al. Clinical and laboratory diagnosis of SARS-CoV-2, the virus causing COVID-19. ACS Infect Dis 2020;6:2319-36. doi: 10.1021/ acsinfecdis.0c00274, PMID 32786280
Syed A. Coronavirus: A mini-review. Int J Curr Res Sci 2020;6:8-10.
Chavez S, Long B, Koyfman A, Liang SY. Coronavirus disease (COVID-19): A primer for emergency physicians. Am J Emerg Med 2021;44:220-9. doi: 10.1016/j.ajem.2020.03.036, PMID 32265065
Tian S, Hu W, Niu L, Liu H, Xu H, Xiao SY. Pulmonary pathologyof early phase 2019 novel coronavirus (COVID-19) pneumonia in two patients with lung cancer. J Thorac Oncol 2020;15:700-4. doi: 10.1016/j.jtho.2020.02.010
National Health Commission of the People’s Republic of China. Guideline for the Diagnosis and Treatment of COVID-19 Infections (Version 1-7). Beijing, China: National Health Commission of the People’s Republic of China; 2020.
Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med 2020;8:420-2. doi: 10.1016/S2213- 2600(20)30076-X, PMID 32085846
Luo W, Yu H, Gou J, Li X, Sun Y, Li J, et al. Clinical Pathology of Critical Patient with Novel Coronavirus Pneumonia (COVID 19). Available from: http://www.preprints.org/manuscript/202002.0407/ v4.Preprints2020;2020020407https
Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 2020;382:1708-20. doi: 10.1056/NEJMoa2002032
Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study. Lancet 2020;395:507-13. doi: 10.1016/S0140-6736(20)30211-7, PMID 32007143
Shi H, Han X, Jiang N, Cao Y, Alwalid O, Gu J, et al. Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: A descriptive study. Lancet Infect Dis. 2020;20:425-34. doi: 10.1016/ S1473-3099(20)30086-4, PMID 32105637
Zhao W, Zhong Z, Xie X, Yu Q, Liu J. Relation between chest CT findings and clinical conditions of coronavirus disease (COVID-19) pneumonia: A multicenter study. AJR Am J Roentgenol 2020;214:1072-7. doi: 10.2214/AJR.20.22976, PMID 32125873
Koo HJ, Lim S, Choe J, Choi SH, Sung H, Do KH. Radiographic and CT features of viral pneumonia. Radiographics 2018;38:719-39. doi: 10.1148/rg.2018170048, PMID 29757717
Franquet T, Müller NL, Giménez A, Martínez S, Madrid M, Domingo P. Infectious pulmonary nodules in immunocompromised patients: Usefulness of computed tomography in predicting their etiology. J Comput Assist Tomogr 2003;27:461-8. doi: 10.1097/00004728- 200307000-00001, PMID 12886125
Xu X, Yu C, Qu J, Zhang L, Jiang S, Huang D, et al. Imaging and clinical features of patients with 2019 novel coronavirus SARS-CoV-2. Eur J Nucl Med Mol Imaging 2020;47:1275-80. doi: 10.1007/s00259- 020-04735-9, PMID 32107577
Wu J, Feng LC, Xian XY, Qiang J, Zhang J, Mao QX, et al. Novel coronavirus pneumonia (COVID-19) CT distribution and sign features. Zhonghua Jie He He Hu Xi Za Zhi 2020;43:321-6. doi: 10.3760/ cma.j.cn112147-20200217-00106, PMID 32125131
Coronavirus Outbreak. Available from: https://www.worldometers. info/coronavirus [Last accessed on 2020 Feb 23].
Xu XW, Wu XX, Jiang XG, Xu KJ, Ying LJ, Ma CL, et al. Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: Retrospective case series. BMJ 2020;368:m606. doi: 10.1136/bmj.m606, PMID 32075786
Cheng ZJ, Shan J. 2019 novel coronavirus: Where we are and what we know. Infection 2020;48:155-63. doi: 10.1007/s15010-020-01401-y, PMID 32072569
Wang XF, Yuan J, Zheng YJ, Chen J, Bao YM, Wang YR, et al. Retracted: Clinical and epidemiological characteristics of 34 children with 2019 novel coronavirus infection in Shenzhen. Zhonghua Er Ke Za Zhi 2020;58:E008. doi: 10.3760/cma.j.issn.0578-1310.2020.0008, PMID 32062875
Chen F, Liu ZS, Zhang FR, Xiong RH, Chen Y, Cheng XF, et al. First case of severe childhood novel coronavirus pneumonia in China. Zhong hua Er Ke Za Zhi 2020;58:E005.
Zeng LK, Tao XW, Yuan WH, Wang J, Liu X, Liu ZS. First case of neonate infected with novel coronavirus pneumonia in China. Zhonghua Er Ke Za Zhi 2020;58:E009. doi: 10.3760/cma.j.issn.0578-1310.2020.0009, PMID 32065520
Lai CC, Shih TP, Ko WC, Tang HJ, Hsueh PR. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges. Int J Antimicrob Agents 2020;55:105924. doi: 10.1016/j.ijantimicag.2020.105924, PMID 32081636
Gu J, Han B, Wang J. COVID-19: Gastrointestinal manifesta-tions and potential fecal-oral transmission. Gastroenterology 2020;158:1518-9. doi: 10.1053/j.gastro.2020.02.054, PMID 32142785
Li YC, Bai WZ, Hashikawa T. The neuroinvasive potential of SARS-CoV2 may be at least partially responsible for the respi-ratory failure of COVID-19 patients. J Med Virol 2020;92:552-5. doi: 10.1002/ jmv.25728, PMID 32104915
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020;395:497-506. doi: 10.1016/S0140-6736(20)30183-5, PMID 31986264
Li H, Wang YM, Xu JY, Cao B. Potential antiviral therapeu-tics for 2019 Novel coronavirus. Zhonghua Jie He Hu Xi Za Zhi 2020;43:E002.
MacLaren G, Fisher D, Brodie D. Preparing for the most critically ill patients with COVID-19: The potential role of extra-corporeal membrane oxygenation. JAMA 2020;323:1245-6. doi: 10.1001/ jama.2020.2342, PMID 32074258
Chen L, Xiong J, Bao L, Shi Y. Convalescent plasma as a potential therapy for COVID-19. Lancet Infect Dis 2020;20:398-400. doi: 10.1016/S1473-3099(20)30141-9, PMID 32113510
Guo YR, Cao QD, Hong ZS, Tan YY, Chen SD, Jin HJ, et al. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak- an update on the status. Mil Med Res 2020;7:11. doi: 10.1186/s40779-020-00240-0, PMID 32169119
Becker RC. COVID-19 treatment update: Follow the scientific evidence. J Thromb Thrombolysis 2020;50:43-53. doi: 10.1007/ s11239-020-02120-9, PMID 32338320
Dehelean CA, Lazureanu V, Coricovac D, Mioc M, Oancea R, Marcovici I, et al. SARS-CoV-2: Repurposed drugs and novel therapeutic approaches- insights into chemical structure-biological activity and toxicological screening. J Clin Med 2020;9:2084. doi: 10.3390/jcm9072084
Gautret P, Lagier JC, Parola P, Hoang VT, Meddeb L, Mailhe M, et al. Hydroxychloroquine and azithromycin as a treatment of COVID-19: Results of an open-label non-randomized clinical trial. Int J Antimicrob Agents 2020;56:105949. doi: 10.1016/j.ijantimicag.2020.105949, PMID 32205204
Serafin MB, Bottega A, Foletto VS, da Rosa TF, Hörner A, Hörner R. Drug repositioning is an alternative for the treatment of coronavirus COVID-19. Int J Antimicrob Agents 2020;55:105969. doi: 10.1016/j. ijantimicag.2020.105969, PMID 32278811
Lim J, Jeon S, Shin HY, Kim MJ, Seong YM, Lee WJ, et al. Case of the index patient who caused tertiary transmission of COVID-19 Infection in Korea: The application of lopinavir/ritonavir for the treatment of COVID-19 infected pneumonia monitored by quantitative RT-PCR. J Korean Med Sci 2020;35:e79. doi: 10.3346/jkms.2020.35.e79, PMID 32056407
Lippi G, Plebani M. Laboratory abnormalities in patients with COVID-2019 infection. Clin Chem Lab Med 2020;58:1131-4. doi: 10.1515/cclm-2020-0198, PMID 32119647
Yang L, Liu S, Liu J, Zhang Z, Wan X, Huang B, et al. COVID-19: Immunopathogenesis and immunotherapeutics. Signal Transduct Target Ther 2020;5:128. doi: 10.1038/s41392-020-00243-2, PMID 32712629
Tortorici MA, Veesler D. Structural insights into coronavirus entry. Adv Virus Res 2019;105:93-116. doi: 10.1016/bs.aivir.2019.08.002, PMID 31522710
Casadevall A, Pirofski LA. The Ebola epidemic crystallizes the potential of passive antibody therapy for infectious diseases. PLoS Pathog 2015;11:e1004717. doi: 10.1371/journal.ppat.1004717, PMID 25905897
Robbiani DF, Gaebler C, Muecksch F, Lorenzi JC, Wang Z, Cho A, et al. Convergent antibody responses to SARS-CoV-2 in convalescent individuals. Nature 2020;584:437-42. doi: 10.1038/s41586-020-2456- 9, PMID 32555388
Wang J, Peng Y, Xu H, Cui Z, Williams RO. The COVID-19 vaccine race: Challenges and opportunities in vaccine formula-tion. AAPS PharmSciTech 2020;21:225. doi: 10.1208/s12249-020-01744-7, PMID 32761294
Calina D, Docea AO, Petrakis D, Egorov AM, Ishmukhametov AA, Gabibov AG, et al. Towards effective COVID-19 vaccines: Updates, perspectives and challenges (Review). Int J Mol Med 2020;46:3-16. doi: 10.3892/ijmm.2020.4596, PMID 32377694
Mcintosh K. coronaviruses: A comparative review. In: Arberw HR, Henlew HP, Jernenk KP, editors. Current Topics in Microbiology and Immunology/Ergebnisse der Mikrobiologie und Immunitatsforschung. Vol. 85. Berlin, Heidelberg: Springer; 1974. p. e129.
Hamre D, Procknow JJ. A new virus isolated from the humanrespiratory tract. Proc Soc Exp Biol Med 1966;121:190-3. doi: 10.3181/00379727- 121-30734, PMID 4285768
Kahn JS, McIntosh K. History and recent advances in coronavirus discovery. Pediatr Infect Dis J 2005;24;S223e7. doi: 10.1097/01. inf.0000188166.17324.60, PMID 16378050
McKie R. Scientists Trace 2002 Sars Virus to Colony of Cave-dwelling Bats in China. Available from: https://www.theguardian.com/world/2017/ dec/10/sars-virus-bats-china-severe-acuterespiratory-syndrome
Novel Coronavirus Update e New Virus to be Called MERS-CoV. WH0; 2020. Available from: https://www.WHO.int [Last accessed on 2020 Apr 15].
Chan JF, Lau SK, To KK, Cheng VC, Woo PC, Yuen KY. Middle East respiratory syndrome coronavirus: another zoonoticbeta coronavirus causing SARS-like disease. Clin Microbiol Rev 2015;28:465-e522.
Epidemiology Working Group for NCIP Epidemic Response, Chinese Center for Disease Control and Prevention. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China. Zhonghua Liu Xing Bing Xue Za Zhi 2020;41:145-51. doi: 10.3760/cma.j.issn.0254-6450.2020.02.003, PMID 32064853
Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: Summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA 2020;323:1239-42. doi: 10.1001/jama.2020.2648, PMID 32091533
Chang AY, Cullen MR, Harrington RA, Barry M. The impact of novel coronavirus COVID-19 on noncommunicable disease patients and health systems: A review. J Intern Med 2021;289:450-62. doi: 10.1111/ joim.13184, PMID 33020988
Bozkurt B, Kovacs R, Harrington B. Joint HFSA/ACC/AHA statement addresses concerns re: Using RAAS Antagonists in COVID-19. J Card Fail 2020;26:370. doi: 10.1016/j.cardfail.2020.04.013, PMID 32439095
Grillo F, Barisione E, Ball L, Mastracci L, Fiocca R. Lung fibrosis: An undervalued finding in COVID-19 pathological series. Lancet Infect Dis 2021;21:e72. doi: 10.1016/S1473-3099(20)30582-X, PMID 32735785
Atabakhsh V. Social Distancing: 6 Ways to Help Older Adults Change their Routines. Australia: The Conversation; 2020.
Beachum L. Experts Debate Whether “Senior-only” Shoppinghours Protect the Elderly from Getting COVID19. Washington Post. Available from: https://www.washingtonpost.com/business/2020/03/17/snior-only-shopping-coronavirus [Last accessed on 2020 Mar 29].
FitzGerald GA. Misguided drug advice for COVID-19. Science 2020;367:1434.
US Food and Drug Administration. FDA Advises Patients on Use of Non-steroidal Anti-inflammatory Drugs (NSAIDs) for COVID-19. Silver Spring, MD: US Food and Drug Administration; 2020. Available from: https:// www.fda.gov/drugs/drugsafety-and-availability/fda-advisespatients-use-non-steroidal-anti-inflammatory-drugs-nsaids-covid-19.
Yusuf IH, Sharma S, Luqmani R, Downes SM. Hydroxychloroquine retinopathy. Eye (Lond) 2017;31:828-45. doi: 10.1038/eye.2016.298, PMID 28282061
Kumar D, Tellier R, Draker R, Levy G, Humar A. Severe acute respiratory syndrome (SARS) in a liver transplant recipient and guidelines for donor SARS screening. Am J Transplant 2003;3:977-81. doi: 10.1034/j.1600-6143.2003.00197.x, PMID 12859532
American College of Surgeons. COVID-19 and Surgery: Clinical Issues and Guidance. Chicago: American College of Surgeons; 2020. Available from: https://www.facs.org/covid-19/clinical-guidance
Impelli M. Italian Man with Coronavirus who Hid Symptoms to Get Rhinoplasty Facing 12 Years in Prison. New York: Newsweek; 2020.
Elizabeth HB. Doctors are being Forced to Ration Care. Don’t Blame Them. Blame Decades of Poor u S. Policy [Opinion]. Available from: https://www.newsweek.com/2020/04/24/doctorsare-being-forced-ration-care-dont-blame-them-blamedecades-poor-us-policy-opinion-1496030.html [Last accessed on 2020 Apr 06].
WHO. Coronavirus disease 2019 (COVID-19) situation report-51. Available from: https://www.who.int/docs/defaultsource/coro¬naviruse/situation-reports/20200311-sitrep-51-covid-19.pdf?s¬fvrsn=1ba62e57_6. [Last accessed on 2020 Mar 14].
WHO-Afro. More than 15 countries in Africa report COVID-19 cases: WHO-Africa. Available from: https://www.afro.who.int/news/more-15- countries-africa-report-covid-19-cases. [Last accessed on 2020 Mar 15].
Published
How to Cite
Issue
Section
Copyright (c) 2022 mandeeep singh mandeep
This work is licensed under a Creative Commons Attribution 4.0 International License.
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.
